In May 2022, the HHS formalized the creation of ARPA as part of an initiative to drive biotech innovation. Mr. Duvall’s appointment comes as the agency celebrates its first 100 days of existence.
In his new position, Mr. Duvall will serve as both acting chief technology officer and CIO.
